Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antagonist”

678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 678
Index total 30,257
Page 18 / 29

Quick answer

This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

678 results for “antagonist” · 30,257 patents in full index Clear search

  1. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    GENERAL REGENERATIVES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  2. US 8323670

    Topical compositions of opioid antagonists and methods for treating skin conditions therewith

    Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  3. US 8318765

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  4. US 8314128

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  5. US 8298525

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  6. US 8278246

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  7. US 8273894

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  8. US 8273780

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  9. US 8268863

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  10. US 8263618

    8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

    Theravance, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  11. US 8263588

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  12. US 8247443

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  13. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  14. US 8247602

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  15. US 8242145

    Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  16. US 8242138

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  17. US 8236821

    Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  18. US 8227421

    Fluorinated GHRH antagonists

    The United States of America represented by the Department of Veteran Affairs · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  19. US 8227417

    HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  20. US 8217038

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  21. US 8217066

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  22. US 8211915

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  23. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  24. US 8211894

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.